Analysis of Liquidity Ratios
Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
Abiomed Inc., liquidity ratios
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
| Liquidity ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Abiomed Inc. current ratio improved from 2020 to 2021 and from 2021 to 2022. |
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Abiomed Inc. quick ratio improved from 2020 to 2021 and from 2021 to 2022. |
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Abiomed Inc. cash ratio improved from 2020 to 2021 and from 2021 to 2022. |
Current Ratio
Abiomed Inc., current ratio calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Current assets | 976,473) | 787,965) | 635,863) | 677,197) | 494,271) | 326,958) | |
| Current liabilities | 138,457) | 128,969) | 131,885) | 105,998) | 84,682) | 69,617) | |
| Liquidity Ratio | |||||||
| Current ratio1 | 7.05 | 6.11 | 4.82 | 6.39 | 5.84 | 4.70 | |
| Benchmarks | |||||||
| Current Ratio, Competitors2 | |||||||
| Abbott Laboratories | 1.63 | 1.85 | 1.72 | 1.44 | — | — | |
| Cigna Group | 0.73 | 0.83 | 0.77 | 0.74 | — | — | |
| CVS Health Corp. | 0.94 | 0.88 | 0.91 | 0.94 | — | — | |
| Danaher Corp. | 1.89 | 1.43 | 1.86 | 5.19 | — | — | |
| Elevance Health Inc. | 1.40 | 1.47 | 1.55 | 1.65 | — | — | |
| Humana Inc. | 1.52 | 1.62 | 1.77 | 1.82 | — | — | |
| Intuitive Surgical Inc. | 4.40 | 5.08 | 6.86 | 4.53 | — | — | |
| Medtronic PLC | 1.86 | 2.65 | 2.13 | 2.59 | 2.28 | — | |
| UnitedHealth Group Inc. | 0.77 | 0.79 | 0.74 | 0.69 | — | — | |
| Current Ratio, Sector | |||||||
| Health Care Equipment & Services | 1.08 | 1.10 | 1.11 | 1.16 | — | — | |
| Current Ratio, Industry | |||||||
| Health Care | 1.15 | 1.20 | 1.20 | 1.33 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Current ratio = Current assets ÷ Current liabilities
= 976,473 ÷ 138,457 = 7.05
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Abiomed Inc. current ratio improved from 2020 to 2021 and from 2021 to 2022. |
Quick Ratio
Abiomed Inc., quick ratio calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Cash and cash equivalents | 132,818) | 232,710) | 192,341) | 121,021) | 42,975) | 39,040) | |
| Short-term marketable securities | 625,789) | 350,985) | 250,775) | 370,677) | 319,274) | 190,908) | |
| Accounts receivable, net | 90,608) | 97,179) | 84,650) | 90,809) | 70,010) | 54,055) | |
| Total quick assets | 849,215) | 680,874) | 527,766) | 582,507) | 432,259) | 284,003) | |
| Current liabilities | 138,457) | 128,969) | 131,885) | 105,998) | 84,682) | 69,617) | |
| Liquidity Ratio | |||||||
| Quick ratio1 | 6.13 | 5.28 | 4.00 | 5.50 | 5.10 | 4.08 | |
| Benchmarks | |||||||
| Quick Ratio, Competitors2 | |||||||
| Abbott Laboratories | 1.06 | 1.28 | 1.14 | 0.88 | — | — | |
| Cigna Group | 0.58 | 0.48 | 0.66 | 0.41 | — | — | |
| CVS Health Corp. | 0.62 | 0.55 | 0.53 | 0.52 | — | — | |
| Danaher Corp. | 1.30 | 0.89 | 1.36 | 4.68 | — | — | |
| Elevance Health Inc. | 1.27 | 1.33 | 1.42 | 1.52 | — | — | |
| Humana Inc. | 1.20 | 1.20 | 1.37 | 1.47 | — | — | |
| Intuitive Surgical Inc. | 3.56 | 4.34 | 5.96 | 3.75 | — | — | |
| Medtronic PLC | 1.30 | 1.91 | 1.50 | 1.90 | 1.71 | — | |
| UnitedHealth Group Inc. | 0.70 | 0.72 | 0.68 | 0.63 | — | — | |
| Quick Ratio, Sector | |||||||
| Health Care Equipment & Services | 0.84 | 0.83 | 0.86 | 0.87 | — | — | |
| Quick Ratio, Industry | |||||||
| Health Care | 0.85 | 0.88 | 0.89 | 1.00 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 849,215 ÷ 138,457 = 6.13
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Abiomed Inc. quick ratio improved from 2020 to 2021 and from 2021 to 2022. |
Cash Ratio
Abiomed Inc., cash ratio calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Cash and cash equivalents | 132,818) | 232,710) | 192,341) | 121,021) | 42,975) | 39,040) | |
| Short-term marketable securities | 625,789) | 350,985) | 250,775) | 370,677) | 319,274) | 190,908) | |
| Total cash assets | 758,607) | 583,695) | 443,116) | 491,698) | 362,249) | 229,948) | |
| Current liabilities | 138,457) | 128,969) | 131,885) | 105,998) | 84,682) | 69,617) | |
| Liquidity Ratio | |||||||
| Cash ratio1 | 5.48 | 4.53 | 3.36 | 4.64 | 4.28 | 3.30 | |
| Benchmarks | |||||||
| Cash Ratio, Competitors2 | |||||||
| Abbott Laboratories | 0.66 | 0.78 | 0.60 | 0.38 | — | — | |
| Cigna Group | 0.17 | 0.14 | 0.32 | 0.14 | — | — | |
| CVS Health Corp. | 0.23 | 0.18 | 0.18 | 0.15 | — | — | |
| Danaher Corp. | 0.71 | 0.32 | 0.82 | 4.04 | — | — | |
| Elevance Health Inc. | 0.86 | 0.95 | 1.04 | 1.08 | — | — | |
| Humana Inc. | 1.10 | 1.08 | 1.29 | 1.37 | — | — | |
| Intuitive Surgical Inc. | 2.90 | 3.66 | 5.30 | 3.13 | — | — | |
| Medtronic PLC | 0.85 | 1.27 | 1.06 | 1.16 | 1.11 | — | |
| UnitedHealth Group Inc. | 0.36 | 0.36 | 0.33 | 0.28 | — | — | |
| Cash Ratio, Sector | |||||||
| Health Care Equipment & Services | 0.47 | 0.46 | 0.51 | 0.51 | — | — | |
| Cash Ratio, Industry | |||||||
| Health Care | 0.47 | 0.51 | 0.52 | 0.63 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 758,607 ÷ 138,457 = 5.48
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Abiomed Inc. cash ratio improved from 2020 to 2021 and from 2021 to 2022. |